BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 27093861)

  • 1. A unique hypofractionated radiotherapy schedule with 51.3 Gy in 18 fractions three times per week for early breast cancer: outcomes including local control, acute and late skin toxicity.
    Vassilis K; Ioannis G; Anna Z; Christina A; Christos A; John K; Porfyrios K; Vassiliki G; John K
    Breast Cancer; 2017 Mar; 24(2):263-270. PubMed ID: 27093861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accelerated hypofractionated adjuvant whole breast radiotherapy with concomitant photon boost after conserving surgery for early stage breast cancer: a prospective evaluation on 463 patients.
    Cante D; Rosa La Porta M; Casanova-Borca V; Sciacero P; Girelli G; Pasquino M; Franco P; Ozzello F
    Breast J; 2011; 17(6):586-93. PubMed ID: 21951485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensity modulated radiation therapy with simultaneous integrated boost in early breast cancer irradiation. Report of feasibility and preliminary toxicity.
    Fiorentino A; Mazzola R; Ricchetti F; Giaj Levra N; Fersino S; Naccarato S; Sicignano G; Ruggieri R; Di Paola G; Massocco A; Gori S; Alongi F
    Cancer Radiother; 2015 Aug; 19(5):289-94. PubMed ID: 26206732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-Course Hypofractionated Radiation Therapy With Boost in Women With Stages 0 to IIIa Breast Cancer: A Phase 2 Trial.
    Ahlawat S; Haffty BG; Goyal S; Kearney T; Kirstein L; Chen C; Moore DF; Khan AJ
    Int J Radiat Oncol Biol Phys; 2016 Jan; 94(1):118-125. PubMed ID: 26700706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accelerated hypofractionated whole-breast irradiation with concomitant daily boost in early breast cancer.
    Kyrgias G; Zygogianni A; Theodorou K; Koukourakis M; Oikonomou A; Kouvaris J; Kouloulias V
    Am J Clin Oncol; 2015 Aug; 38(4):358-63. PubMed ID: 23934132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One versus three weeks hypofractionated whole breast radiotherapy for early breast cancer treatment: the FAST-Forward phase III RCT.
    Brunt AM; Haviland JS; Wheatley DA; Sydenham MA; Bloomfield DJ; Chan C; Cleator S; Coles CE; Donovan E; Fleming H; Glynn D; Goodman A; Griffin S; Hopwood P; Kirby AM; Kirwan CC; Nabi Z; Patel J; Sawyer E; Somaiah N; Syndikus I; Venables K; Yarnold JR; Bliss JM;
    Health Technol Assess; 2023 Nov; 27(25):1-176. PubMed ID: 37991196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypofractionated radiotherapy for breast cancers--preliminary results from a tertiary care center in eastern India.
    Nandi M; Mahata A; Mallick I; Achari R; Chatterjee S
    Asian Pac J Cancer Prev; 2014; 15(6):2505-10. PubMed ID: 24761855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypofractionated radiotherapy for breast cancer patients treated by breast-conserving surgery: short-term morbidity and preliminary results.
    Plataniotis GA; Theofanopoulou MA; Sotiriadou K; Kyrgias G
    Breast Cancer; 2010; 17(1):42-7. PubMed ID: 19350358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypofractionated irradiation in elderly patients with breast cancer after breast conserving surgery and mastectomy : Analysis of 205 cases.
    Doré M; Cutuli B; Cellier P; Campion L; Le Blanc M
    Radiat Oncol; 2015 Aug; 10():161. PubMed ID: 26238442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of two radiation boost schedules in postlumpectomy patients with breast cancer.
    Yadav BS; Sharma SC; Singh G; Dahiya D
    J Cancer Res Ther; 2020; 16(6):1344-1349. PubMed ID: 33342794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early-stage breast cancer treated with 3-week accelerated whole-breast radiation therapy and concomitant boost.
    Chadha M; Woode R; Sillanpaa J; Lucido D; Boolbol SK; Kirstein L; Osborne MP; Feldman S; Harrison LB
    Int J Radiat Oncol Biol Phys; 2013 May; 86(1):40-4. PubMed ID: 23290443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Weekly concomitant boost in adjuvant radiotherapy for patients with early breast cancer: preliminary results on feasibility.
    Corvò R; Giudici S; Maggio F; Bevegni M; Sampietro C; Lucido MR; Orsatti M
    Tumori; 2008; 94(5):706-11. PubMed ID: 19112945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Preliminary results of whole breast helical tomotherapy with simultaneous integrated boost in the adjuvant treatment of breast cancer].
    Liem X; Chira C; Fourquet A; Campana F; Peurien D; Fournier-Bidoz N; Kirova YM
    Cancer Radiother; 2014 Jan; 18(1):15-22. PubMed ID: 24316350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypofractionated Breast Radiation: Shorter Scheme, Lower Toxicity.
    Linares I; Tovar MI; Zurita M; Guerrero R; Expósito M; Del Moral R
    Clin Breast Cancer; 2016 Aug; 16(4):262-8. PubMed ID: 26454613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary results of electron intraoperative therapy boost and hypofractionated external beam radiotherapy after breast-conserving surgery in premenopausal women.
    Ivaldi GB; Leonardi MC; Orecchia R; Zerini D; Morra A; Galimberti V; Gatti G; Luini A; Veronesi P; Ciocca M; Sangalli C; Fodor C; Veronesi U
    Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):485-93. PubMed ID: 18407434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors influencing acute and late toxicity in the era of adjuvant hypofractionated breast radiotherapy.
    De Santis MC; Bonfantini F; Di Salvo F; Dispinzieri M; Mantero E; Soncini F; Baili P; Sant M; Bianchi G; Maggi C; Di Cosimo S; Agresti R; Pignoli E; Valdagni R; Lozza L
    Breast; 2016 Oct; 29():90-5. PubMed ID: 27476083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicity and cosmetic outcome of hypofractionated whole-breast radiotherapy: predictive clinical and dosimetric factors.
    Ciammella P; Podgornii A; Galeandro M; Micera R; Ramundo D; Palmieri T; Cagni E; Iotti C
    Radiat Oncol; 2014 Apr; 9():97. PubMed ID: 24762173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A biologically competitive 21 days hypofractionation scheme with weekly concomitant boost in breast cancer radiotherapy feasibility acute sub-acute and short term late effects.
    Guenzi M; Vagge S; Azinwi NC; D'Alonzo A; Belgioia L; Garelli S; Gusinu M; Corvò R
    Radiat Oncol; 2010 Nov; 5():111. PubMed ID: 21092219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of intermediate time between chemotherapy and hypofractionated radiotherapy to the radiation induced skin toxicity for breast adjuvant treatment.
    Zygogianni A; Kouloulias V; Antypas C; Armpilia C; Kyrgias G; Kouvaris J
    Breast J; 2014; 20(1):74-8. PubMed ID: 24237451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypofractionation with no boost after breast conservation in early-stage breast cancer patients.
    Arcadipane F; Franco P; De Colle C; Rondi N; Di Muzio J; Pelle E; Martini S; Ala A; Airoldi M; Donadio M; De Sanctis C; Castellano I; Ragona R; Ricardi U
    Med Oncol; 2016 Oct; 33(10):108. PubMed ID: 27573380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.